Study of the Scientific Production on Leishmaniasis in Latin America

Perilla-Gonzalez, Yuliana; Gómez-Suta, Daniela; Delgado-Osorio, Nathalia; Hurtado-Hurtado, Natalia; Baquero-Rodriguez, Juan D.; Lopez-Isaza, Andres F.; Lagos-Grisales, Guillermo J.; Villegas, Soraya; Rodríguez‐Morales, Alfonso J.

doi:10.2174/1574891x10666150410165445

Cited by 21 publications

(18 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Bibliometric analysis, a well-established research method in information science, has been commonly used for revealing research efforts. It is used for the quantitative description of documents in diseases, such as a group of diseases or a specific one [8, 9]. The five countries might differ from each other in R&D for neglected diseases due to the varied disease burden, health policy and investment.…”

Section: Introductionmentioning

confidence: 99%

Bibliometric study of research and development for neglected diseases in the BRICS

Bai

Huang

et al. 2016

Infect Dis Poverty

View full text Add to dashboard Cite

BackgroundLarge numbers of people are suffering from a group of diseases that mainly affect developing countries, as there are no available or affordable products for prevention or treatment. Research and development (R&D) for these diseases is still a low priority on the health agenda. Brazil, Russia, India, China and South Africa (BRICS) are quickly growing economies and having more and more positive impact on global health. Additionally, their R&D capacity is believed to be enhanced through decades of investment in education and life science research. The BRICS, as a group of emerging and developing countries, are expected to make greater contributions to solving the problem that mainly affects the entire developing countries community. However, there has been little research to provide a macroscopic overview of BRICS’ effort in R&D for neglected diseases. The aim of this study is to investigate scientific production in BRICS countries in this area and their main research hotspots.MethodsGlobal relevant literature was searched without time limits through PubMed and high yield countries were identified using GoPubMed. Literature up to the end of 2013 from the BRICS was obtained and high frequency words were extracted and clustered using Bibliography Item Co-occurrence Mining System 2.0 (BICOMS) and Graphical Clustering Toolkit 1.0 (gCLUTO).ResultsIn total, 32, 47, 51, 31 and 44 high frequency words from Brazil, Russia, India, China and South Africa respectively were extracted for clustering analysis. The clustering indicated that eight diseases were research hotspots in BRICS countries. India had the most extensive hotspots and Brazil came in second. The other three countries shared common research foci: helminthiasis, Human Immunodeficiency Virus infection and Acquired Immune Deficiency Syndrome (HIV/AIDS) and tuberculosis.ConclusionsDeveloped countries still make the majority of contributions to R&D on neglected diseases, but BRICS countries are playing a growing role. Instead of the “big three diseases” (HIV/AIDS, malaria and tuberculosis) recognized by WHO, the BRICS focus more on major causes of disease burden in their own countries. Disease burden and domestic policy, especially patent law, exert primary influence on the research focus.Electronic supplementary materialThe online version of this article (doi:10.1186/s40249-016-0182-1) contains supplementary material, which is available to authorized users.

show abstract

Section: Introductionmentioning

confidence: 99%

Bibliometric study of research and development for neglected diseases in the BRICS

Bai

Huang

et al. 2016

Infect Dis Poverty

View full text Add to dashboard Cite

show abstract

“…In earlier days, the bibliometric studies were covering the different aspects of neglected tropical diseases such as Latin American studies [9][10] and social science research. [11] But after 2011 onwards specific research were conducted related to leishmaniasis in general; [12][13] or for specific countries and region such as Iran, [14][15] Latin America, [16] South America. [17] The bibliometric study focusing India were reported in parasitic and neglected tropical disease; [18] lymphatic filariasis; [19] and other neglected tropical diseases such as Ascariasis/Toxocariasis, [20] and Schistosomiasis.…”

Section: Resultsmentioning

confidence: 99%

India's Contribution and Research Impact Leishmaniasis Research: A Bibliometric Analysis

Ram¹

2018

JSCIRES

View full text Add to dashboard Cite

“…As occurred in multiple other topics, related to tropical diseases [15-19], affecting significantly developing countries, research on them is led by developed countries. This situation is also seen with research on nitazoxanide.…”

Section: Discussionmentioning

confidence: 99%

“…Included databases do not represent all scientific and biomedical journals published; in fact, many articles of importance may appear in journals other than those indexed in used databases or may not be indexed as the case of contributions made to scientific conferences and meetings. However, the recognized quality of the publications included in these databases and their coverage means that the documents selected constitute a more than representative sample of the international research on nitazoxanide [15-19]. In the near future, it would be interesting also to perform studies on the prescribing patterns and costs of this drug use by countries, as has been now commonly reported in Colombia for other drugs [21].…”

Section: Discussionmentioning

confidence: 99%

Bibliometric Assessment of the Global Scientific Production of Nitazoxanide

Rodríguez‐Morales

Martínez-Pulgarín

Muñoz

et al. 2017

Cureus

View full text Add to dashboard Cite

IntroductionNitazoxanide is a member of a new class of drug, thiazolides, and it was discovered in 1984 with antimicrobial activity effect against anaerobic bacteria, Hepatitis virus, protozoa, and helminths.MethodsA bibliometric study on four databases (1984-2016) – Medline, Scopus, LILACS, and SciELO – characterizing the global scientific production of nitazoxanide. We determined the quantity, quality (number of citations), and types of studies developed by each country, characterizing them by years, international cooperation, development, place of publication, authors (with its H-index), and groups with higher impact.ResultsThere were 512 articles in Medline – the higher scientific production is from the USA (19.71%), Switzerland (7.51%), and Mexico (7.27%). There were 1,440 articles in Scopus – from the USA (8.98%), Mexico (2.13%), and India (1.65%). There were 405 articles in LILACS – from Mexico (4.69%), the USA (4.2%), and Peru (2.47%). There were 47 articles in SciELO – from Brazil (34.04%), Venezuela (21.28%), and Colombia (14.89%). The H-index of nitazoxanide is 75 – the USA (26), Egypt (12), and Canada (10) were the countries contributing more with that.ConclusionsNitazoxanide research has been highly important. Nevertheless, it is relatively limited when compared with other drugs. Its research has been led by the USA, as revealed in this bibliometric assessment. Although some developing countries, where it is used especially for protozoa and helminths, probably have its influence, and this explains the fact that Mexico and India, among others, are the top countries in the scientific production of this anti-infective agent. This bibliometric study evidenced a relatively low number of publications, however, it has been increased in recent years.

show abstract

Study of the Scientific Production on Leishmaniasis in Latin America

Cited by 21 publications

References 19 publications

Bibliometric study of research and development for neglected diseases in the BRICS

Bibliometric study of research and development for neglected diseases in the BRICS

India's Contribution and Research Impact Leishmaniasis Research: A Bibliometric Analysis

Bibliometric Assessment of the Global Scientific Production of Nitazoxanide

Contact Info

Product

Resources

About